Guard Therapeutics International AB (GUARD) — Working Capital to Net Assets Ratio
Guard Therapeutics International AB (GUARD) has a Working Capital to Net Assets ratio of 101.2% as of September 2025. Working capital of Skr56.31 Million (current assets of Skr70.88 Million minus current liabilities of Skr14.56 Million) is measured against net assets of Skr55.63 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Guard Therapeutics International AB to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guard Therapeutics International AB Working Capital to Net Assets (2010–2024)
This chart shows how Guard Therapeutics International AB's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2010 to 2024. As of September 2025, the ratio stands at 101.2%, reflecting working capital of Skr56.31 Million against net assets of Skr55.63 Million SEK. See Guard Therapeutics International AB (GUARD) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Guard Therapeutics International AB (2010–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guard Therapeutics International AB from 2010 to 2024, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Guard Therapeutics International AB (GUARD) total market value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.1% | Skr38.01 Million | Skr37.97 Million | Skr55.74 Million | Skr17.73 Million | ▼ -2.7 pp |
| 2023 | 102.8% | Skr68.61 Million | Skr66.73 Million | Skr85.23 Million | Skr16.61 Million | ▲ +1.4 pp |
| 2022 | 101.4% | Skr179.90 Million | Skr177.36 Million | Skr202.59 Million | Skr22.70 Million | ▼ -0.7 pp |
| 2021 | 102.1% | Skr179.47 Million | Skr175.78 Million | Skr190.41 Million | Skr10.94 Million | ▼ -4.2 pp |
| 2020 | 106.3% | Skr84.67 Million | Skr79.69 Million | Skr91.18 Million | Skr6.50 Million | ▲ +10.2 pp |
| 2019 | 96.1% | Skr50.58 Million | Skr52.62 Million | Skr55.87 Million | Skr5.30 Million | ▼ -396.9 pp |
| 2018 | 493.0% | Skr-14.49 Million | Skr-2.94 Million | Skr15.73 Million | Skr30.21 Million | ▲ +499.6 pp |
| 2017 | -6.6% | Skr-2.11 Million | Skr31.96 Million | Skr9.58 Million | Skr11.68 Million | ▲ +3.4 pp |
| 2016 | -10.0% | Skr-3.03 Million | Skr30.34 Million | Skr9.10 Million | Skr12.13 Million | ▼ -44.7 pp |
| 2015 | 34.7% | Skr14.82 Million | Skr42.69 Million | Skr21.46 Million | Skr6.64 Million | ▲ +31.6 pp |
| 2014 | 3.1% | Skr1.61 Million | Skr52.25 Million | Skr4.93 Million | Skr3.32 Million | ▼ -2.0 pp |
| 2013 | 5.1% | Skr1.29 Million | Skr25.42 Million | Skr5.65 Million | Skr4.36 Million | ▼ -48.0 pp |
| 2012 | 53.1% | Skr16.24 Million | Skr30.58 Million | Skr18.48 Million | Skr2.25 Million | ▲ +75.5 pp |
| 2011 | -22.4% | Skr-473.89K | Skr2.12 Million | Skr795.44K | Skr1.27 Million | ▼ 0.0 pp |
| 2010 | -22.4% | Skr-689.66K | Skr3.08 Million | Skr182.16K | Skr871.82K | — |